MedTrace Logo

PVP-Guided Decongestive Therapy in HF

NCT05217342 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 586

Last updated 2023-03-14

No results posted yet for this study

Summary

The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalization, emergency department visits) compared to standard evaluation.

Conditions

Interventions

DRUG

Diuretic therapy

Standard diuretic therapy according to the current guidelines

Sponsors & Collaborators

  • Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

    collaborator OTHER

  • Başakşehir Çam & Sakura City Hospital

    collaborator OTHER_GOV

  • Marmara University

    lead OTHER

Principal Investigators

  • Emre K Aslanger, Assoc. Prof. · Marmara University

  • Dursun Akaslan, MD · Marmara University

  • Özlem Yıldırımtürk, Prof. · Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

  • Duygu İnan, MD · Basaksehir Cam & Sakura State Hospital

  • Yelda Saltan, MD · Basaksehir Cam & Sakura State Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-01-01
Completion
2024-01-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05217342 on ClinicalTrials.gov